Watch These Eli Lilly Stock Price Levels as Weight-Loss Drug Competition Rises

Eli Lilly (LLY) shares dropped much than 4% connected Thursday, continuing a hasty retreat from their record high earlier this month, arsenic investors assessed nan imaginable effect of a promising caller weight-loss injection developed by Viking Therapeutics (VKTX) connected nan drugmaker’s ain measurement anti-obesity drug, Mounjaro. Last week, Eli Lilly shares tumbled aft Swiss pharmaceutical patient Roche Holding AG said its caller non-injectable weight-loss supplier has shown encouraging early shape data.

Below, we return a person look astatine Eli Lilly’s floor plan and constituent retired important value levels to watch retired for utilizing technical analysis.

Chart Signals Potential Reversal

Eli Lilly shares person trended consistently higher since nan 50-day moving mean (MA) crossed supra nan 200-day MA successful April past twelvemonth to shape a bullish golden cross signal. However, nan stock’s technicals constituent to a imaginable reversal.

Firstly, arsenic nan supplier maker’s banal climbed to a grounds precocious earlier this month, nan relative spot scale (RSI) made a comparatively little highest to create a bearish divergence, indicating slowing buying momentum. Secondly, nan value closed decisively beneath a multi-month uptrend statement and nan 50-day MA connected Thursday, suggesting a breakdown of nan longer-term trend.

Watch These Key Support Levels

Eli Lilly shares were down 0.1% astatine $820.00 successful premarket trading astir 2 hours earlier Friday's opening bell. The banal has mislaid 15% of its worth since hitting its all-time intraday precocious of $966.10 connected July 15.

If Eli Lilly shares proceed their decline, investors should show 3 cardinal areas connected nan floor plan wherever they could brushwood support.

The first level to watch sits astir $790, an area wherever nan banal whitethorn pull buying liking adjacent a horizontal line connecting an extended play of consolidation betwixt February and May wrong nan longer-term uptrend.

A adjacent beneath this area could spot a autumn to nan $725 region, wherever nan value would apt find support from nan little information of nan consolidation play discussed above, which besides presently intimately aligns pinch nan rising 200-day MA.

Finally, a much important driblet opens nan doorway to a retest of nan $625 level, wherever buyers whitethorn beryllium happy to scoop up shares adjacent a trendline linking nan October and November 2023 swing highs pinch nan debased of a insignificant pullback successful January this year.

Bear Trap Still a Possibility

If nan existent breakdown turns retired to beryllium a bear trap, which lures investors into trading earlier nan value makes a punctual recovery, we tin estimate an upside target by utilizing a bars pattern.

We do this by extracting nan trending move from April to July and applying it from Thursday’s low, which predicts a price target of astir $1,060.

The comments, opinions, and analyses expressed connected Investopedia are for informational purposes only. Read our warranty and liability disclaimer for much info.

As of nan day this article was written, nan writer does not ain immoderate of nan supra securities.